Alert
Close

We’re Giving Away $50,000! Enter Now. See Official Rules

HIGHLIGHTS

Open
AARP Staying Sharp: Keep Your Brain Healthy

AARP REALPAD

The tablet with free 24/7 customer support. Learn More

AARP VETERAN MEMBERSHIP

Military and Veterans Discount

CONTESTS AND SWEEPS

AARP’s Picture Your Retirement Sweepstakes

Enter the $50K Picture Your Retirement Sweepstakes. Ends 8/31/15. No purchase necessary. Enter for Official Rules.

KEEP BRAIN ACTIVE!

AARP Games - Play Now!

Webinars

Learn From the Experts

Sign up now for an upcoming webinar or find materials from a past session.

AARP BOOKS

Planning for Long-Term Care for Dummies

Get expert advice on planning for your own or a relative’s future care needs.

Learning centers

Get smart strategies for managing health conditions.

 

Arthritis

Heart Disease

Diabetes

Most Popular

Viewed

Health Discovery

New Test for Prostate Cancer Proposed

Study suggests a way to refine current PSA tests

Approved in Europe, skeptics in United States

The FDA's European counterpart has already approved the test, he says. Catalona estimates that 18 percent of the 50 million American men who annually have their PSA levels tested fall into the diagnostic gray zone, so if the test is approved here, some 9 million men might be eligible to take it.

Not everyone shares Catalona's enthusiasm, however.

James L. Mohler, M.D., a urologist at the Roswell Park Cancer Institute and chair of the National Comprehensive Cancer Network's prostate cancer treatment guideline panel, says Catalona "basically improved the ability of the PSA to separate the benign from the cancer a little bit."

The study itself had some shortcomings, Mohler says.

Although Catalona "showed some differences that were interesting," the study should be repeated with more men who are studied over a longer period of time to see whether the Pro-PSA test really is more accurate.

Oliver Sartor, M.D., a urology professor and medical director of the Tulane University Cancer Center, agrees that the test is "better" at detecting who has cancer. But he cautions it's not ready for prime time, adding it may not help patients avoid biopsies. "Furthermore, the test clearly is not good enough to decide whether or not a cancer needs to be treated or not," he says.

"It moves us forward a little bit, but this isn't the answer to prostate cancer that we've all been looking for."

Michael Haederle is a freelance writer whose work has appeared in People, the New York Times and the Los Angeles Times.

You may also like: Coffee can help men who have certain prostate cancers. >>

Topic Alerts

You can get weekly email alerts on the topics below. Just click “Follow.”

Manage Alerts

Processing

Please wait...

progress bar, please wait

Tell Us WhatYou Think

Please leave your comment below.

Advertisement

Discounts & Benefits

From companies that meet the high standards of service and quality set by AARP.

Walgreens 1 discount membership aarp

Members can earn 50 points per $1 spent on select health & wellness products at Walgreens.

member benefit aarp hear usa

Members save 15% on easy listening devices and more at the HearUSA Hearing Shop.

Eye Med 4 Membership Benefit AARP Discount

Members save up to 60% on eye exams and 30% on glasses at Target Optical.

Membership Benefits Discounts Email Genius

Brain boost? Get AARP email for access to memory exercises & more that help you focus.

Rewards for Good

Your Points Balance:

Learn More

Earn points for completing free online activities designed to enrich your life.

Find more ways to earn points

Redeem your points to save on merchandise, travel, and more.

Find more ways to redeem points

Advertisement